BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9784039)

  • 1. The use of azathioprine in severe adult atopic eczema.
    Buckley DA; Baldwin P; Rogers S
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):137-40. PubMed ID: 9784039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further experience of using azathioprine in the treatment of severe atopic dermatitis.
    Hughes R; Collins P; Rogers S
    Clin Exp Dermatol; 2008 Nov; 33(6):710-1. PubMed ID: 18681884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
    Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
    J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability at 3 and 6 months following use of azathioprine for recalcitrant atopic dermatitis in children and young adults.
    Hon KL; Ching GK; Leung TF; Chow CM; Lee KK; Ng PC
    J Dermatolog Treat; 2009; 20(3):141-5. PubMed ID: 18951236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
    Zoller L; Ramon M; Bergman R
    Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Safety of azathioprine therapy adjusted to thiopurine methyltransferase activity in the treatment of infantile atopic dermatitis. Report on 7 cases].
    Martel RM; Melwani P; Islas D; Peñate Y; Borrego L
    Actas Dermosifiliogr; 2010 Jun; 101(5):415-20. PubMed ID: 20525484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy, tolerability and safety of a new oral formulation of Sandimmun--Sandimmun Neoral in severe refractory atopic dermatitis.
    Atakan N; Erdem C
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):240-6. PubMed ID: 9883436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial.
    Meggitt SJ; Gray JC; Reynolds NJ
    Lancet; 2006 Mar; 367(9513):839-46. PubMed ID: 16530578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients.
    Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S
    Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis.
    Hijnen DJ; ten Berge O; Timmer-de Mik L; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):85-9. PubMed ID: 17207173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study.
    van Velsen SG; Haeck IM; Bruijnzeel-Koomen CA; de Bruin-Weller MS
    Br J Dermatol; 2009 Mar; 160(3):687-91. PubMed ID: 19120337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azathioprine in refractory sprue: results from a prospective, open-label study.
    Mauriño E; Niveloni S; Cherñavsky A; Pedreira S; Mazure R; Vazquez H; Reyes H; Fiorini A; Smecuol E; Cabanne A; Capucchio M; Kogan Z; Bai JC
    Am J Gastroenterol; 2002 Oct; 97(10):2595-602. PubMed ID: 12385445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up.
    Baumgart DC; Pintoffl JP; Sturm A; Wiedenmann B; Dignass AU
    Am J Gastroenterol; 2006 May; 101(5):1048-56. PubMed ID: 16573777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
    Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
    Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine as a therapeutic modality for the treatment of severe adult atopic dermatitis.
    Verma KK; Mittal R
    Indian J Dermatol Venereol Leprol; 2001; 67(4):189-91. PubMed ID: 17664737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: a two-year study.
    Papp KA; Werfel T; Fölster-Holst R; Ortonne JP; Potter PC; de Prost Y; Davidson MJ; Barbier N; Goertz HP; Paul C
    J Am Acad Dermatol; 2005 Feb; 52(2):240-6. PubMed ID: 15692468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug-induced alveolitis associated with infliximab/azathioprine therapy].
    El-Hag K; Dercken HG; Prenzel R; Hölzle E
    Pneumologie; 2008 Apr; 62(4):204-8. PubMed ID: 18270925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.